These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30349435)

  • 21. Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.
    Wihastuti TA; Heriansyah T; Hanifa H; Andarini S; Sholichah Z; Sulfia YH; Adam AA; Refialdinata J; Lutfiana NC
    Endocr Regul; 2018 Apr; 52(2):69-75. PubMed ID: 29715185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined serum free light chain levels are associated with carotid atherosclerosis in type 2 diabetes mellitus.
    Aberer F; Tripolt NJ; Scharnagl H; Zedler J; Eder M; Oulhaj A; Stojakovic T; Sourij H
    Diab Vasc Dis Res; 2018 Mar; 15(2):162-164. PubMed ID: 29189047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
    Shapiro J; Cohen AD; David M; Hodak E; Chodik G; Viner A; Kremer E; Heymann A
    J Am Acad Dermatol; 2007 Apr; 56(4):629-34. PubMed ID: 17157411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations of carotid intima-media thickness with endothelial function and atherosclerosis degree in patients with type 2 diabetes mellitus.
    Wang M; Sui J; Wang S; Wang X
    Clin Hemorheol Microcirc; 2019; 72(4):431-439. PubMed ID: 31006671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis.
    Theuma P; Fonseca VA
    Curr Diab Rep; 2003 Jun; 3(3):248-54. PubMed ID: 12762974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs.
    Hess RS; Kass PH; Van Winkle TJ
    J Vet Intern Med; 2003; 17(4):489-94. PubMed ID: 12892299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus.
    Rubinat E; Marsal JR; Vidal T; Cebrian C; Falguera M; Vilanova MB; Betriu À; Fernández E; Franch J; Mauricio D
    J Cardiovasc Nurs; 2016; 31(2):E1-7. PubMed ID: 25829137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atherosclerosis in diabetes mellitus].
    Yamada N
    Nihon Rinsho; 2006 Nov; 64(11):1985-90. PubMed ID: 17087287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes and type of diet as determinant factor in the progression of atherosclerosis].
    Perales-Torres AL; Castillo-Ruíz O; Castañeda Licón MT; Alemán-Castillo SE; Jiménez Andrade JM
    Arch Cardiol Mex; 2016; 86(4):326-334. PubMed ID: 26775035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of cardiovascular disease in diabetes mellitus.
    Rodriguez-Araujo G; Nakagami H
    Cardiovasc Endocrinol Metab; 2018 Mar; 7(1):4-9. PubMed ID: 31646271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity.
    Gaiz A; Mosawy S; Colson N; Singh I
    Biomed Pharmacother; 2017 Oct; 94():679-686. PubMed ID: 28787703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with diabetes mellitus and atherosclerosis; a role for cytomegalovirus?
    Visseren FL; Bouter KP; Pon MJ; Hoekstra JB; Erkelens DW; Diepersloot RJ
    Diabetes Res Clin Pract; 1997 Apr; 36(1):49-55. PubMed ID: 9187415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of atherosclerosis in diabetes and hypertension.
    Shantaram V
    Clin Exp Hypertens; 1999; 21(1-2):69-77. PubMed ID: 10052643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic lipid markers of atherosclerosis in type 2 diabetic patients on program haemodialysis.
    Archakova TV; Nedosugova LV; Nikitina NA; Melnichenko AA; Sobenin IA
    Ter Arkh; 2018 Nov; 90(10):40-45. PubMed ID: 30701794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of abnormal circulating insulin levels to atherosclerosis.
    Stout RW
    Atherosclerosis; 1977 May; 27(1):1-13. PubMed ID: 857812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
    Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3.
    Robertson LA; Kim AJ; Werstuck GH
    Can J Physiol Pharmacol; 2006 Jan; 84(1):39-48. PubMed ID: 16845889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary thrombosis and diabetes mellitus: the influence of coronary thrombosis on the metabolism of the diabetic patient.
    WEINSTEIN A
    Am Pract Dig Treat; 1950 Dec; 1(12):1233-7. PubMed ID: 14790185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.